Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


PLGA Foundation


Address

98 Random Farms Drive
Chappaqua, NY 10514

Description

The mission of PLGA Foundation (Pediatric Low Grade Astrocytomas) is to act as a central resource and a portal for information for parents, patients, families, clinicians, researchers, specialists, and other non-profit institutions seeking information about low-grade (grade 1) gliomas and juvenile pilocytic astrocytoma (JPA). JPA is the most common childhood brain tumor type diagnosed in children from birth to 19 years of age. JPA is also a tumor that is reported in adults, ages 20 to 50. The ultimate goal of PLGA Foundation is to accelerate the pace of JPA scientific research by acting both as a fundraiser and as a catalyst for all JPA-designed fundraising activities.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.